Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.

Ulrich-Vinther M, Carmody EE, Goater JJ, S balle K, O'Keefe RJ, Schwarz EM.

J Bone Joint Surg Am. 2002 Aug;84-A(8):1405-12.

PMID:
12177271
[PubMed - indexed for MEDLINE]
3.

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.

Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM.

J Bone Joint Surg Br. 2001 Aug;83(6):902-11. Review.

PMID:
11521937
[PubMed - indexed for MEDLINE]
Free Article
4.

RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.

Ritchlin CT, Schwarz EM, O'Keefe RJ, Looney RJ.

J Musculoskelet Neuronal Interact. 2004 Sep;4(3):276-84. Review.

PMID:
15615495
[PubMed - indexed for MEDLINE]
Free Article
5.

New insights in myeloma-induced osteolysis.

Barillé-Nion S, Bataille R.

Leuk Lymphoma. 2003 Sep;44(9):1463-7. Review.

PMID:
14565645
[PubMed - indexed for MEDLINE]
6.

Recombinant adeno-associated virus transduction and integration.

Schultz BR, Chamberlain JS.

Mol Ther. 2008 Jul;16(7):1189-99. doi: 10.1038/mt.2008.103. Epub 2008 May 20. Review.

PMID:
18500252
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Immune responses to adeno-associated virus and its recombinant vectors.

Sun JY, Anand-Jawa V, Chatterjee S, Wong KK.

Gene Ther. 2003 Jun;10(11):964-76. Review.

PMID:
12756417
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk